Galectin Therapeutics Inc (NASDAQ:GALT)

3.56
Delayed Data
As of 4:00pm ET
 +0.15 / +4.40%
Today’s Change
1.28
Today|||52-Week Range
6.74
+6.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-15.8M-20.0M-21.4M-16.2M
 
 
 
 
 
Depreciation10.0K7.0K7.0K1.0K
 
 
 
 
 
Total Other Cash Flow4.5M3.4M2.5M1.1M
 
 
 
 
 
Funds From Operations-11.3M-16.6M-19.0M-15.1M
 
 
 
 
 
Funds From/For Other Operating Expenses1.1M363.0K-2.5M804.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-12.4M-17.0M-16.4M-15.9M
 
 
 
 
 
 
InvestingIncrease In Investments-400.0K0.000.000.00
 
 
Net Cash Flow Investing-400.0K0.000.000.00
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale31.5M13.7M5.9M3.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing31.5M13.7M5.9M3.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash18.6M-3.3M-10.5M-12.3M